Arjun Balar - Dissemin

Language
Login

All papers authored by Arjun Balar

This paper was not found in any repository, but could be made available legally by the author.

2024 Y. Loriot

ORCID

, D. P. Petrylak, A. Rezazadeh Kalebasty, A. Fléchon, R. K. Jain, S. Gupta, M. Bupathi, P. Beuzeboc, P. Palmbos

ORCID

, A. V. Balar

ORCID

, C. E. Kyriakopoulos, D. Pouessel, C. N. Sternberg, J. Tonelli, M. Sierecki and 4 other authors

TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes

Upload

This paper is made freely available by the publisher.

2022 Shilpa Gupta, Joaquim Bellmunt, Guru P. Sonpavde, Petros Grivas, Elizabeth R. Plimack, Noah M. Hahn, Sumanta K. Pal, Thomas W. Flaig, Arlene O. Siefker-Radtke, Matt D. Galsky, Jonathan E. Rosenberg, Andrea B. Apolo, Dean F. Bajorin, Arjun Vasant Balar

ORCID

Defining “platinum-ineligible” patients with metastatic urothelial cancer (mUC).

Download from doi.org

This paper is made freely available by the publisher.

Samuel A. Funt

ORCID

, Michael Lattanzi

ORCID

, Karissa Whiting

ORCID

, Hikmat Al-Ahmadie

ORCID

, Colleen Quinlan, Min Yuen Teo

ORCID

, Chung-Han Lee

ORCID

ORCID

, Danielle Zimmerman

ORCID

, Deaglan McHugh

ORCID

, Arlyn Apollo, Trey D. Durdin

ORCID

ORCID

, Jeffrey Kamradt, Maged Khalil and 24 other authors

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

Download from doi.org

This paper is made freely available by the publisher.

Joaquim Bellmunt

ORCID

, Ronald de Wit

ORCID

ORCID

, Miguel A. Climent, Daniel P. Petrylak, Jae-Lyun Lee

ORCID

, Lawrence Fong

ORCID

, Andrea Necchi

ORCID

, Cora N. Sternberg

ORCID

, Peter H. O'Donnell

ORCID

, Thomas Powles

ORCID

, Elizabeth R. Plimack

ORCID

, Dean F. Bajorin

ORCID

, Arjun V. Balar

ORCID

, Daniel Castellano and 16 other authors

Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials

Download from aacrjournals.org

This paper is made freely available by the publisher.

2021 Scott T. Tagawa

ORCID

, Arjun V. Balar

ORCID

, Daniel P. Petrylak

ORCID

, Arash Rezazadeh Kalebasty

ORCID

, Yohann Loriot, Aude Fléchon, Rohit K. Jain, Neeraj Agarwal

ORCID

, Manojkumar Bupathi, Philippe Barthelemy, Philippe Beuzeboc, Phillip Palmbos, Christos E. Kyriakopoulos

ORCID

, Damien Pouessel, Cora N. Sternberg

ORCID

and 4 other authors

TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Evan Y. Yu, Daniel P. Petrylak, Peter H. O'Donnell, Jae-Lyun Lee, Michiel S. van der Heijden, Yohann Loriot, Mark N. Stein, Andrea Necchi, Takahiro Kojima, Michael R. Harrison, Se Hoon Park, David I. Quinn, Elisabeth I. Heath, Jonathan E. Rosenberg, Joyce Steinberg and 5 other authors

Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial

Upload

This paper is made freely available by the publisher.

Guilhem Richard, Anne S. De Groot, Gary D. Steinberg, Tzintzuni I. Garcia, Alec Kacew, Matthew Ardito, William D. Martin, Gad Berdugo, Michael F. Princiotta, Arjun V. Balar

ORCID

, Randy F. Sweis

Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival

Download from www.nature.com

This paper was not found in any repository, but could be made available legally by the author.

Min Yuen Teo, Jose Mauricio Mota, Karissa A. Whiting, Han A. Li, Samuel A. Funt, Chung-Han Lee, David B. Solit

ORCID

, Matthew I. Milowsky, Eugene Pietzak, Guido Dalbagni, Bernard H. Bochner, Irina Ostrovnaya, Jonathan E. Rosenberg, Gopa Iyer, Hikmat Al-Ahmadie and 2 other authors

Corrigendum re “Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma” [Eur Urol 2020;78:907–15]

Upload

This paper is made freely available by the publisher.

Robert A. Huddart

ORCID

, Mustafa Özgüroğlu

ORCID

, Bob Zhong, Arlene O. Siefker-Radtke

ORCID

, Arjun V. Balar

ORCID

, Mehmet A. Bilen, Thomas Powles, Aristotelis Bamias, Daniel Castellano, David W. Pook

ORCID

, Maged F. Khalil, Michiel S. Van Der Heijden, Linda Santiago, Vadim S. Koshkin

ORCID

, David Chien and 3 other authors

PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2020 T. B. Powles, M. S. van der Heijden, A. V. Balar

ORCID

, P. O'Donnell, C. Massard, J. Walker, A. Gupta, N. Angra, J. Cairns, B. Turriziani, M. C. Rebelatto, M. Scott, S. Wildsmith

13P PD-L1 prevalence in advanced urothelial carcinoma by demographic and clinical characteristics

Upload

This paper was not found in any repository, but could be made available legally by the author.

Y. Loriot, A. V. Balar

ORCID

, D. P. Petrylak, S. T. Tagawa, A. Rezazadeh, A. Fléchon, R. Jain, N. Agarwal, M. Bupathi, P. Barthélémy, P. Beuzeboc, P. L. Palmbos, C. E. Kyriakopoulos, D. Pouessel, C. N. Sternberg and 4 other authors

LBA24 TROPHY-U-01 cohort 1 final results: A phase II study of sacituzumab govitecan (SG) in metastatic urothelial cancer (mUC) that has progressed after platinum (PLT) and checkpoint inhibitors (CPI)

Upload

This paper was not found in any repository, but could be made available legally by the author.

P. Grivas, A. V. Balar

ORCID

, J. Vuky, R. de Wit, N. J. Vogelzang, T. K. Choueiri, D. Bajorin, D. Castellano Gauna, W. Gerritsen, H. Gurney, D. I. Quinn, S. Culine, Y. Fradet, A. Saadatpour, A. Loboda and 5 other authors

744P Association between gene expression signatures (sigs) and pembrolizumab (pembro) efficacy in patients (pts) with advanced urothelial cancer (UC)

Upload

This paper was not found in any repository, but could be made available legally by the author.

P. O'Donnell, M. D. Galsky, J. E. Rosenberg, D. P. Petrylak, A. V. Balar

ORCID

, B. A. McGregor, E. Heath, E. Y. Yu, D. I. Quinn, N. M. Hahn, M. Campbell, S.-Y. Liang, J. Steinberg, Y. Loriot

746P EV-201: Long-term results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and PD-1/PD-L1 inhibitors

Upload

This paper was not found in any repository, but could be made available legally by the author.

J. Powderly, T. Shimizu, P. Lorusso, A. Razak, K. D. Miller, A. V. Balar

ORCID

, J. Bruix, L. S. Michel, M. Blaney, X. Guan, S. Lacy, S. Lally, S. Lambert, R. Leibman, G. Vosganian and 2 other authors

596TiP Phase I first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumours

Upload

This paper was not found in any repository, but could be made available legally by the author.

Min Yuen Teo, Jose Mauricio Mota

ORCID

, Karissa A. Whiting, Han A. Li

ORCID

, Samuel A. Funt

ORCID

, Chung-Han Lee, David B. Solit

ORCID

, Hikmat Al-Ahmadie, Matthew I. Milowsky, Arjun V. Balar

ORCID

, Eugene Pietzak, Guido Dalbagni, Bernard H. Bochner, Irina Ostrovnaya, Dean F. Bajorin and 2 other authors

Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

J. L. Boormans, R. De Wit, G. S. Kulkarni, E. M. Uchio, M. Roumiguié, L. E. M. Krieger, E. A. Singer, A. M. Kamat, P. Grivas, H. K. Seo, H. Nishiyama, B. R. Konethy, T. Saretsky, H. Li, K. Nam and 3 other authors

Updated follow-up from KEYNOTE-057: Phase 2 study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG)

Upload

This paper is made freely available by the publisher.

Jacqueline Vuky, Arjun V. Balar

ORCID

, Daniel Castellano, Peter H. O’Donnell, Petros Grivas, Joaquim Bellmunt, Thomas Powles, Dean Bajorin, Noah M. Hahn, Mary J. Savage, Xiao Fang, James Luke Godwin, Tara L. Frenkl, Blanca Homet Moreno, Ronald de Wit and 1 other authors

Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Petros Grivas, Elizabeth R. Plimack

ORCID

, Arjun V. Balar

ORCID

, Daniel Castellano, Peter H. O’Donnell, Joaquim Bellmunt, Thomas Powles, Noah M. Hahn, Ronald de Wit, Dean F. Bajorin, Misoo C. Ellison, Tara L. Frenkl

ORCID

, James L. Godwin

ORCID

, Jacqueline Vuky

Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status

Upload

This paper was not found in any repository, but could be made available legally by the author.

Ashish M. Kamat

ORCID

, Seth P. Lerner, Michael O’Donnell

ORCID

, Mihaela V. Georgieva, Min Yang, Brant A. Inman, Wassim Kassouf, Stephen A. Boorjian, Mark D. Tyson, Girish S. Kulkarni, Sam S. Chang, Badrinath R. Konety, Robert S. Svatek, Arjun Balar

ORCID

, J. Alfred Witjes

Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non–muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Arjun Balar

ORCID

Pd-l1 Prevalence in Advanced Urothelial Carcinoma by Demographic and Clinical Characteristics

Upload

Missing publications? Search for publications with a matching author name.